Interstitial lung disease before and after COVID-19: a double threat?

por Valenzuela, Claudia, Waterer, Grant, Raghu, Ganesh
Publicado 2021

Pulmonary Fibrosis in the Time of COVID-19

por Buendia-Roldan, Ivette, Valenzuela, Claudia, Selman, Moisés
Publicado 2022

Variability in Global Prevalence of Interstitial Lung Disease

por Kaul, Bhavika, Cottin, Vincent, Collard, Harold R., Valenzuela, Claudia
Publicado 2021

Encuesta realizada sobre la indicación y la utilización de la rehabilitación respiratoria en pacientes con fibrosis pulmonar idiopática por neumólogos españoles

por Romero Ortiz, Ana Dolores, Ros Lucas, José Antonio, Cejudo Ramos, Pilar, Valenzuela, Claudia
Publicado 2021

Ongoing challenges in pulmonary fibrosis and insights from the nintedanib clinical programme

por Valenzuela, Claudia, Torrisi, Sebastiano Emanuele, Kahn, Nicolas, Quaresma, Manuel, Stowasser, Susanne, Kreuter, Michael
Publicado 2020

Patients’ and Healthcare Professionals’ Experiences of Idiopathic Pulmonary Fibrosis Treatment with the Pirfenidone 801 mg Tablet Formulation: A Multinational Survey

por Lancaster, Lisa H., Valenzuela, Claudia, Mason, Wendi, Neurohr, Claus, Ripamonti, Elena, Kirchgaessler, Klaus-Uwe, Cottin, Vincent
Publicado 2020

Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?

por Wijsenbeek, Marlies S., Bonella, Francesco, Orsatti, Leticia, Russell, Anne-Marie, Valenzuela, Claudia, Wuyts, Wim A., Baile, Walter F.
Publicado 2022

Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung Diseases

por Bonella, Francesco, Cottin, Vincent, Valenzuela, Claudia, Wijsenbeek, Marlies, Voss, Florian, Rohr, Klaus B., Stowasser, Susanne, Maher, Toby M.
Publicado 2022

Manejo de las enfermedades pulmonares intersticiales difusas (EPID) asociadas a enfermedades autoinmunes, por el neumólogo en las diferentes unidades de EPID en España

por Acosta Fernández, Orlando, Aburto Barrenetxea, Myriam, Llanos González, Ana Belén, Rodríguez Nieto, María Jesús, Molina Molina, María, Valenzuela, Claudia
Publicado 2022

Demographic and clinical profile of idiopathic pulmonary fibrosis patients in Spain: the SEPAR National Registry

por Fernández-Fabrellas, Estrella, Molina-Molina, María, Soriano, Joan B., Portal, José Antonio Rodríguez, Ancochea, Julio, Valenzuela, Claudia, Xaubet, Antoni
Publicado 2019

Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease: The STARLINER Study

por Wijsenbeek, Marlies, Bendstrup, Elisabeth, Valenzuela, Claudia, Henry, Michael T., Moor, Catharina, Bengus, Monica, Perjesi, Andras, Gilberg, Frank, Kirchgaessler, Klaus-Uwe, Vancheri, Carlo
Publicado 2018

Plain language summary: Clinical study of BI 1015550 as a potential treatment for idiopathic pulmonary fibrosis

por Richeldi, Luca, Azuma, Arata, Cottin, Vincent, Hesslinger, Christian, Stowasser, Susanne, Valenzuela, Claudia, Wijsenbeek, Marlies S, Zoz, Donald F, Voss, Florian, Maher, Toby M
Publicado 2022

Role of C-reactive protein as a biomarker for prediction of the severity of pulmonary exacerbations in patients with cystic fibrosis

por Girón-Moreno, Rosa Maria, Justicia, José L, Yamamoto, Sara, Valenzuela, Claudia, Cisneros, Carolina, Gómez-Punter, Rosa Mar, Fernandes-Vasconcelos, Gilda, Ancochea, Julio
Publicado 2014

Analysis of body mass index, weight loss and progression of idiopathic pulmonary fibrosis

por Jouneau, Stéphane, Crestani, Bruno, Thibault, Ronan, Lederlin, Mathieu, Vernhet, Laurent, Valenzuela, Claudia, Wijsenbeek, Marlies, Kreuter, Michael, Stansen, Wibke, Quaresma, Manuel, Cottin, Vincent
Publicado 2020

COVID-19 follow-up programmes across Europe: an ERS END-COVID CRC survey

por Valenzuela, Claudia, Nigro, Mattia, Chalmers, James D., Wagers, Scott, Aujayeb, Avinash, Hellemons, Merel E., Löffler-Ragg, Judith, Brightling, Christopher E., Aliberti, Stefano
Publicado 2022

Role of imaging in progressive-fibrosing interstitial lung diseases

por Walsh, Simon L.F., Devaraj, Anand, Enghelmayer, Juan Ignacio, Kishi, Kazuma, Silva, Rafael S., Patel, Nina, Rossman, Milton D., Valenzuela, Claudia, Vancheri, Carlo
Publicado 2018

Long-term safety and efficacy of tobramycin in the management of cystic fibrosis

por Vázquez-Espinosa, Emma, Girón, Rosa María, Gómez-Punter, Rosa Mar, García-Castillo, Elena, Valenzuela, Claudia, Cisneros, Carolina, Zamora, Enrique, García-Pérez, F Javier, Ancochea, Julio
Publicado 2015

Tumor-Associated Granulomas Preceding a Diagnosis of Thoracic Sarcoidosis: A Retrospective, Single-Center Cohort Study

por Muñoz-Hernández, Patricia, Valdivia-Mazeyra, Mariel, Ancochea, Julio, Alonso Pérez, Tamara, Rajas, Olga, Valenzuela, Claudia, Hernández-Muñiz, Susana, Esteban-Peris, Amparo, Jiménez-Heffernan, José A.
Publicado 2021

Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis

por Flaherty, Kevin R., Fell, Charlene D., Huggins, J. Terrill, Nunes, Hilario, Sussman, Robert, Valenzuela, Claudia, Petzinger, Ute, Stauffer, John L., Gilberg, Frank, Bengus, Monica, Wijsenbeek, Marlies
Publicado 2018

ABO blood group as a determinant of COVID-19 and Long COVID: An observational, longitudinal, large study

por Soriano, Joan B., Peláez, Adrián, Busquets, Xavier, Rodrigo-García, María, Pérez-Urría, Elena Ávalos, Alonso, Tamara, Girón, Rosa, Valenzuela, Claudia, Marcos, Celeste, García-Castillo, Elena, Ancochea, Julio
Publicado 2023